Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia

Autor: Nedeljković Milan A., Beleslin Branko, Tešić Milorad, Vujisić-Tešić Bosiljka, Vukčević Vladan, Stanković Goran, Stojković Siniša, Orlić Dejan, Potpara Tatjana, Mujović Nebojša, Marinković Milan, Petrović Olga, Grygier Marek, Protopopov Alexey V., Kanjuh Vladimir, Ašanin Milika
Jazyk: English<br />Serbian
Rok vydání: 2017
Předmět:
Zdroj: Vojnosanitetski Pregled, Vol 74, Iss 4, Pp 378-385 (2017)
Druh dokumentu: article
ISSN: 0042-8450
2406-0720
DOI: 10.2298/VSP160205202N
Popis: Introduction. Atrial fibrillation (AF) is the major cause ofstroke, particularly in older patients over 75 years of age. EuropeanSociety of Cardiology guidelines recommend chronic anticoagulationtherapy in patients with atrial fibrillation ifCHA2DS2-VASc score is ≥ 1 (CHA2DS2-VASc score for estimatingthe risk of stroke in patients with non-rheumatic AFconsisting of the first letters of patients condition: C – congestiveheart failure; H – hypertension; A2 – age ≥ 75 years; D –diabetes mellitus; S2 – prior stroke, transitory ischaemic attack(TIA) or thrombolism; V – vascular disease; A – age 65–74years; Sc – sex category). However, a significant number of patientshave a high bleeding risk, or are contraindicated forchronic oral anticoagulation, and present a group of patients inwhom alternative treatment options for thromboembolic preventionare required. Transcatheter percutaneous left atrial appendageclosure (LAAC) devices have been recommended inpatients with contraindications for chronic anticoagulanttherapy. Case report. We present our first three patients withnonvalvular AF and contraindications for chronic anticoagulanttherapy who were successfully treated with implantation ofLAAC Watchman device in Catheterization Laboratory of theClinic for Cardiology, Clinical Center of Serbia in BelgradeConclusion. Our initial results with Watchman LAAC deviceare promising and encouraging, providing real alternative in patientswith non-valvular AF and contraindication for chronicanticoagulant therapy and high bleeding risk.
Databáze: Directory of Open Access Journals
Externí odkaz: